US Stem Cell Inc (USRM)

[Dragon Lady]

Lol, "They did a great job with with Angel. Mirror was not communicated well IMO"

What? "Great job"??

1) Angel just got "canned" ending in nothing per the latest PR of Jan 29th, 2015? What was "great job" about that? It was a big ole PR pump IMO? What's it ever going to amount to now?

http://finance.yahoo.com/news/bioheart-announces-phase-angel-trial-110823792.html

QUOTE:
"Kristin Comella, Bioheart's Chief Science Officer, said, "We were so excited to see brisk enrollment in the study. Once we collect preliminary safety and efficacy, we will expand the study into a Phase II trial."

REALITY- it's NOT becoming a phase II trial. It's CANCELLED as of the Jan 29th, 2015 ole PR, no explanation given. End of great "story" PR.

2) MIRROR was "not communicated well"?? Well, that's a real "nice" way of putting it IMHO. How bout MIRROR was hyped in PR as a "Phase 3 FULLY FUNDED BY BIOHEART" and well, sorta, kinda like, well, just NEVER HAPPENED REALLY we come to find out. If that's defined as "not communicated well", then that's an awfully nice way of putting it IMO. I'd use "other" descriptions for that one- and they'd be a lot more harsh than "Not communicated well". I think there's other terms used to describe when something is highly "talked up" shall we say, when "vast claims" are made about something in print, then one finds out that "something", well was kinda-sorta just NOT TRUE in the end and never really happened as described, like not being "FULLY FUNDED BY BIOHEART"??? It's kinda hard in my book to understand claiming something is "FULLY FUNDED" when it never actually took place, and then later, SEC filings become full of statements like, "MIRROR IS WAITING TO BE FUNDED"?? Just a tad bit of "contradiction" shall we say IMO? A tad maybe?

Orginal MIRROR PR full of vast claims- I mean it sounded great right?

http://www.marketwired.com/press-release/bioheart-announces-phase-iii-mirror-trial-for-myocell-initiated-otcqb-bhrt-1807938.htm

July 2nd 2013, that PR said MIRROR was rocking and rolling- moving ahead and "FULLY FUNDED BY BIOHEART" and had "enrolled ONE patient".

Well, then nothing really happened after that. Never really heard about old MIRROR the "phase 3 trial" again.

From the latest 10-Q filing for the period ended Sept 30th, 2014 PAGE 29:

"We have initiated and enrolled our first patient in the MIRROR trial in 2013. The trial is very similar to the MARVEL trial but focusses on sites outside the US. We will continue enrollment in the MIRROR trial once we have secured sufficient funds."

Wait, "secured sufficient funds"?? What? But the original PR from July 2nd 2013 said the following:

"The MIRROR trial is fully funded by Bioheart and will be conducted at up to 35 centers in North and South America. The trial is designed to enroll up to 126 patients over a 12 month time period. "

So what happened? So it was never "fully funded" in the first place, now was it? PR hype versus reality in my book. The PR sure sounded "good" - but it just never really ever happened.

Cause now we find out, just a week or so ago via another PR (with no explanations given by the way)

PR of Jan 29th, 2015:

http://finance.yahoo.com/news/bioheart-updates-diversifies-clinical-development-150000986.html

Quote:

"The Company has no further plans to advance its ANGEL and MIRROR clinical development programs."

And just like that- ole MIRROR, the much hyped, big ole "phase 3" that NEVER REALLY WAS, it's just gone. Vanished. Cancelled. No further explanation given.

Hardly a "not communicated well" in my book. It's way bigger a problem than that to me, IMO. It raises a whole PR credibility issue to me, for me personally. That original PR about MIRROR and the reality of what really happened on MIRROR, might as well be a 1000 miles apart IMO. The initial PR hype was just that to me, a big hype "story". Cause none of it ended up happening- not "up to" 35 centers, or the "up to" 126 patients enrolled, let alone any actual "phase 3 trial" ever even taking place, let alone was it ever "FULLY FUNDED" by Bioheart. It all just never happened.

The day that original PR was released way back in July 2013, I remember I never understood vague language like "up to" wording being used?? That wording, legal-eze, meant to me if they enrolled ONE patient at ONE center, then they'd met the legal definition of "up to". I've never seen a medical trial described using wording such as "up to" for the size and number of participants, never. It would normally state something like, "This trial will enroll a minimum of 87 patients to meet the end point requirements with a maximum of 109 and will take place at 35 centers located across the geographic area of XYZ". Something definitive like that- not vague and open ended wording such as "up to".

MIRROR never made any sense to me- and now I'm not surprised one bit in the way it's turned out. Like so many other things BHRT put great sounding "PR" out about- it's just vanished, never really amounting to anything, in this case never really even happening, and now never to be heard about again. From my experience- nothing new for ole Bioheart. Can't count or remember how many times that's been the case in my experience?